This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Safer injection guide: Difference between revisions
>David Hedlund m |
>David Hedlund m m |
||
| Line 76: | Line 76: | ||
===Sterile water for injection=== | ===Sterile water for injection=== | ||
[[File:Sterilewater.jpg|245px|thumb|right|The USP standards for water for injection includes a "target limit response" of 500 µg of Carbon/L, and 10 [https://en.wikipedia.org/wiki/Colony-forming_unit {{abbr|CFU|colony forming units}}]/100mL.<ref>https://www.usp.org/frequently-asked-questions/water-pharmaceutical-and-analytical-purposes</ref>]] | [[File:Sterilewater.jpg|245px|thumb|right|The USP standards for water for injection includes a "target limit response" of 500 µg of Carbon/L, and 10 [https://en.wikipedia.org/wiki/Colony-forming_unit {{abbr|CFU|colony forming units}}]/100mL.<ref>https://www.usp.org/frequently-asked-questions/water-pharmaceutical-and-analytical-purposes</ref>]] | ||
'''Sterile [https://en.wikipedia.org/wiki/Water_for_injection water for injection]''' is used to create solutions that will be administered by injection. Water for injection is generally made by distillation or reverse osmosis.<ref name=Gh2004>{{cite book|last1=Ghosh|first1=Tapash K.|last2=Jasti|first2=Bhaskara R.|title=Theory and Practice of Contemporary Pharmaceutics|date=2004|publisher=CRC Press|isbn=9780203644478|page=396|url=https://books.google.com/books?id=whiC7aSFLY8C&pg=PA396|language=en|url-status=live|archiveurl=https://web.archive.org/web/20170116162803/https://books.google.ca/books?id=whiC7aSFLY8C&pg=PA396|archivedate=2017-01-16}}</ref> | '''Sterile [https://en.wikipedia.org/wiki/Water_for_injection water for injection]''' is used to create solutions that will be administered by injection. Water for injection is generally made by distillation or reverse osmosis.<ref>https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018632s051lbl.pdf</ref><ref name=Gh2004>{{cite book|last1=Ghosh|first1=Tapash K.|last2=Jasti|first2=Bhaskara R.|title=Theory and Practice of Contemporary Pharmaceutics|date=2004|publisher=CRC Press|isbn=9780203644478|page=396|url=https://books.google.com/books?id=whiC7aSFLY8C&pg=PA396|language=en|url-status=live|archiveurl=https://web.archive.org/web/20170116162803/https://books.google.ca/books?id=whiC7aSFLY8C&pg=PA396|archivedate=2017-01-16}}</ref> | ||
Syringe designed saline drops (e.g. Wallace Cameron Ultra Saline Minipod) are distributed in modern needle-exchange programmes as they can be used efficiently either by injection or ophthalmic (if the drug is potent in small doses) route of administer which is compared to intravenous use; by demonstration, the elimination of latanoprost acid from plasma is rapid (half-life 17 minutes) after either ophthalmic or intravenous administration.<ref>{{cite web|url=https://www.drugs.com/mmx/latanoprost.html|title=Latanoprost Drug Information, Professional|publisher=Drugs.com|access-date=18 September 2014}}</ref> | Syringe designed saline drops (e.g. Wallace Cameron Ultra Saline Minipod) are distributed in modern needle-exchange programmes as they can be used efficiently either by injection or ophthalmic (if the drug is potent in small doses) route of administer which is compared to intravenous use; by demonstration, the elimination of latanoprost acid from plasma is rapid (half-life 17 minutes) after either ophthalmic or intravenous administration.<ref>{{cite web|url=https://www.drugs.com/mmx/latanoprost.html|title=Latanoprost Drug Information, Professional|publisher=Drugs.com|access-date=18 September 2014}}</ref> | ||